{"nct_id":"NCT03737851","title":"A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis","status":"COMPLETED","status_verified_date":"2023-12","start_date":"2018-12-11","start_date_type":"ACTUAL","primary_completion_date":"2021-08-09","primary_completion_date_type":"ACTUAL","completion_date":"2021-09-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}